ASRS
RARE icon

Arizona State Retirement System’s Ultragenyx Pharmaceutical RARE Stock Holding History

Arizona State Retirement System’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$500K Sell
23,850
-119
-0.5% -$2.68K ﹤0.01% 1458
2025
Q4 		$551K Sell
23,969
-1,207
-5% -$39.7K ﹤0.01% 1422
2025
Q3 		$757K Buy
25,176
+533
+2% +$16K ﹤0.01% 1286
2025
Q2 		$896K Buy
24,643
+814
+3% +$29.3K 0.01% 1145
2025
Q1 		$863K Sell
23,829
-209
-0.9% -$8.7K 0.01% 1138
2024
Q4 		$1.01M Buy
24,038
+568
+2% +$28.2K 0.01% 1094
2024
Q3 		$1.3M Buy
23,470
+2,726
+13% +$139K 0.01% 972
2024
Q2 		$853K Buy
20,744
+434
+2% +$18.5K 0.01% 1110
2024
Q1 		$948K Buy
20,310
+227
+1% +$10.7K 0.01% 1068
2023
Q4 		$960K Sell
20,083
-80
-0.4% -$3.1K 0.01% 1065
2023
Q3 		$719K Buy
20,163
+441
+2% +$17.5K 0.01% 1178
2023
Q2 		$910K Buy
19,722
+425
+2% +$19.7K 0.01% 1075
2023
Q1 		$774K Buy
19,297
+523
+3% +$22.4K 0.01% 1138
2022
Q4 		$870K Buy
18,774
+721
+4% +$28.4K 0.01% 1050
2022
Q3 		$748K Buy
18,053
+190
+1% +$9.76K 0.01% 1089
2022
Q2 		$1.07M Buy
17,863
+359
+2% +$22.1K 0.01% 930
2022
Q1 		$1.27M Buy
17,504
+159
+0.9% +$11.1K 0.01% 935
2021
Q4 		$1.46M Sell
17,345
-118
-0.7% -$9.6K 0.01% 885
2021
Q3 		$1.57M Buy
17,463
+174
+1% +$15.7K 0.01% 847
2021
Q2 		$1.65M Sell
17,289
-1,006
-5% -$105K 0.01% 829
2021
Q1 		$2.08M Buy
18,295
+1,602
+10% +$218K 0.02% 711
2020
Q4 		$2.31M Sell
16,693
-435
-3% -$51.6K 0.02% 628
2020
Q3 		$1.41M Buy
17,128
+4,715
+38% +$391K 0.01% 759
2020
Q2 		$971K Sell
12,413
-471
-4% -$31.2K 0.01% 773
2020
Q1 		$572K Buy
+12,884
New +$669K 0.01% 938

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Arizona State Retirement System's RARE Position: Q1 2026 in Review

Arizona State Retirement System reduced its Ultragenyx Pharmaceutical (RARE) stake by 0.5% in Q1 2026, selling an estimated $2.68K and leaving 23,850 shares worth $500K. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Arizona State Retirement System first reported a position in RARE in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.31M in Q4 2020. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Arizona State Retirement System held 23,850 shares of Ultragenyx Pharmaceutical worth $500K as of Q1 2026.
  • Arizona State Retirement System sold 119 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $2.68K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1458 holding.
  • Arizona State Retirement System first reported a position in Ultragenyx Pharmaceutical in Q1 2020 and has held it in 25 quarters since.
  • Arizona State Retirement System's Ultragenyx Pharmaceutical position peaked at $2.31M in Q4 2020.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.